Perrigo Company (
) will begin trading ex-dividend on February 26, 2014. A cash
dividend payment of $0.105 per share is scheduled to be paid on
March 18, 2014. Shareholders who purchased PRGO stock prior to the
ex-dividend date are eligible for the cash dividend payment. At the
current stock price of $160.51, the dividend yield is .07%.
The previous trading day's last sale of PRGO was $160.51,
representing a -1.13% decrease from the 52 week high of $162.35 and
a 11.11% increase over the 52 week low of $144.46.
PRGO is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). PRGO's current earnings per share, an indicator of a company's
profitability, is $2.74. Zacks Investment Research reports PRGO's
forecasted earnings growth in 2014 as 17.53%, compared to an
industry average of 9.7%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to PRGO through an Exchange
Traded Fund [ETF]?
The following ETF(s) have PRGO as a top-10 holding:
- Market Vectors Israel ETF (
- iShares U.S. Pharmaceutical ETF (
- iShares Morningstar Mid Growth Index Fund (
- WCM BNY Mellon Focused Growth ADR ETF (
The top-performing ETF of this group is IHE with an increase of
24.28% over the last 100 days. ISRA has the highest percent
weighting of PRGO at 9.66%.